The impact of ORF19.36.1 in the pathobiology of Candida albicansMICROBIAL PATHOGENESISIF3.52023-12-010PRE
Photodynamic inactivation by hypericin-P123 on azole-resistant isolates of the Trichophyton rubrum complex as planktonic cells and biofilmPHOTODIAGNOSIS AND PHOTODYNAMIC THERAPYIF2.62023-12-011PRE
Promising onychomycosis treatment with hypericin-mediated photodynamic therapy: Case reportsPHOTODIAGNOSIS AND PHOTODYNAMIC THERAPYIF2.62023-06-012PRE
Cell wall associated proteins involved in filamentation with impact on the virulence of Candida albicans (vol 258, 1, 2022)MICROBIOLOGICAL RESEARCHIF6.92022-08-010OAAI
Cell wall associated proteins involved in filamentation with impact on the virulence of Candida albicansMICROBIOLOGICAL RESEARCHIF6.92022-05-0114OAAI
Serial systemic candidiasis alters Candida albicans macromorphology associated with enhancement of virulence attributesMICROBIAL PATHOGENESISIF3.52022-03-013OAAI
Hypericin-P123-photodynamic therapy in an ex vivo model as an alternative treatment approach for onychomycosis caused by Fusarium spp.PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPYIF2.62021-09-0113PREAI
A systematic review of photodynamic therapy as an antiviral treatment: Potential guidance for dealing with SARS-CoV-2PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPYIF2.62021-06-0136OAAI
Fungicidal Activity of a Safe 1,3,4-Oxadiazole Derivative Against Candida albicansPATHOGENSIF3.32021-03-0711OAAI
Nanoencapsulated hypericin in P-123 associated with photodynamic therapy for the treatment of dermatophytosisJOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGYIF3.72021-02-0115PREAI
Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicansFRONTIERS IN MICROBIOLOGYIF4.52019-09-1224OAAI
Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatmentPLOS NEGLECTED TROPICAL DISEASESIF3.42019-06-0417OAAI